DEUTSCHE BANK AG\ - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$39,000
+2.6%
28,161
-10.0%
0.00%
Q4 2021$38,000
-51.3%
31,283
+5.2%
0.00%
Q3 2021$78,000
-95.5%
29,727
-91.0%
0.00%
-100.0%
Q2 2021$1,752,000
-20.7%
330,617
+0.9%
0.00%0.0%
Q1 2021$2,208,000
+982.4%
327,604
+991.6%
0.00%
Q4 2020$204,000
+21.4%
30,010
+33.3%
0.00%
Q3 2020$168,000
-63.0%
22,506
-48.0%
0.00%
Q2 2020$454,000
+558.0%
43,312
+454.1%
0.00%
Q1 2020$69,000
+146.4%
7,817
+0.7%
0.00%
Q4 2019$28,000
+33.3%
7,761
+33.9%
0.00%
Q3 2019$21,000
-78.4%
5,796
-62.6%
0.00%
Q2 2019$97,000
-34.0%
15,490
-13.9%
0.00%
Q1 2019$147,000
-88.8%
17,993
-93.3%
0.00%
-100.0%
Q4 2018$1,310,000
+5.5%
268,054
+113.0%
0.00%
Q3 2018$1,242,000
+71.1%
125,839
+137.9%
0.00%
Q2 2018$726,000
+107.4%
52,897
+138.7%
0.00%
Q1 2018$350,000
-0.6%
22,165
+16.1%
0.00%
Q4 2017$352,000
+84.3%
19,096
+126.1%
0.00%
Q3 2017$191,0008,4450.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,333,333$5,073,000100.00%
CAXTON CORP 1,483,343$5,644,0006.36%
Polaris Venture Management Co. V, L.L.C. 1,197,032$4,555,0002.59%
RA Capital Management 4,537,478$17,265,0001.03%
Orbimed Advisors 3,447,840$13,119,0000.25%
Matisse Capital 46,500$177,0000.22%
PURA VIDA INVESTMENTS, LLC 332,831$1,266,0000.22%
Sofinnova Investments, Inc. 478,206$1,819,0000.16%
HARBOURVEST PARTNERS LLC 99,186$377,0000.16%
ALGERT GLOBAL LLC 47,195$180,0000.07%
View complete list of KALA PHARMACEUTICALS INC shareholders